Publication: Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis
Issued Date
2014-01-01
Resource Type
ISSN
1873281X
14729792
14729792
Other identifier(s)
2-s2.0-84891558600
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Tuberculosis. Vol.94, No.1 (2014), 20-25
Suggested Citation
Suporn Pholwat, Suzanne Stroup, Jean Gratz, Varittha Trangan, Suporn Foongladda, Happiness Kumburu, Saumu Pazia Juma, Gibson Kibiki, Eric Houpt Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis. Tuberculosis. Vol.94, No.1 (2014), 20-25. doi:10.1016/j.tube.2013.10.006 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/34066
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis
Other Contributor(s)
Abstract
Summary Pyrazinamide (PZA) plays the important role in shortening the tuberculosis treatment period and in treating MDR-TB. Phenotypic PZA susceptibility methods are limited because they require specialized acidified media, which increases costs and complexity. In this study we developed a genotypic high resolution melt (HRM) analysis technique to detect pncA mutations associated with PZA resistant Mycobacterium tuberculosis. Seven overlapping primer pairs were designed to cover the entire pncA gene and upstream regions. Each gene segment was individually amplified by real-time PCR followed by HRM analysis. The assay was evaluated on 98 clinical M. tuberculosis isolates (41 PZA susceptible by MGIT method, 55 PZA resistant, 2 undetermined). HRM was 94% concordant to full-length sequencing results, with most discrepancies attributable to mixed populations per HRM or transversions. Sequencing and HRM yielded 82% and 84% concordance, respectively, to phenotypic PZA susceptibilities by MGIT, with most discrepancies attributable to isolates with wild-type pncA but phenotypic PZA resistance. This HRM technique is a simple and high-throughput method for screening clinical M. tuberculosis samples for PZA resistance. © 2013 Elsevier Ltd. All rights reserved.